Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

Recruiting

Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

Sponsor:

OptiSkin Medical

Code:

NCT05265234

Conditions

Eczema

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Optical Coherence Tomography

Reflectance confocal microscopy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by OptiSkin Medical on 2022-03-03.